Pfizer’s maternal vaccine, Abrysvo, and Sanofi’s monoclonal antibody, Beyfortus, were approved for expectant mothers and infants in the U.S. earlier…
Two new immunizations could protect babies from RSV, the leading cause of hospitalization in infants.
These hurdles threaten to prevent babies from receiving protection this winter and to hinder the launches of both drugs. RSV typically feels like a cold for adults but can be dangerous for newborns, seniors and adults with chronic medical conditions. Complications from the virus are the leading cause of hospitalization among newborns.Until now, the only preventative treatment was another monoclonal antibody called Synagis that's given once a month during RSV season, which generally runs from fall through spring. It costs about $1,000 a dose and is recommended only for babies at high risk for severe illness.
Laura Riley, chair of obstetrics and gynecology at Weill Cornell Medicine and New York-Presbyterian, originally wasn't planning to administer Abrysvo in her office. The shot carries a list price of $295, making it more expensive than other maternal vaccines like one for whooping cough, for example, that costs about $50.But Riley said she heard from patients struggling to get vaccinated at pharmacies that were already administering the shot to seniors.
Australia Latest News, Australia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Cold And Flu Season Is Coming: When To Test For Covid-19, Flu And RSVI’m the director of Clinical Virology and Vice Chair of Practice in the Department of Laboratory Medicine and Pathology at Mayo Clinic. I’m the past-President of the Pan American Society for Clinical Virology and specialize in the diagnosis of infectious diseases, such as Covid-19 and influenza. In 2020, my laboratory was one of the first in the United States to develop a molecular test to detect Covid-19. I specialize in infectious diseases and novel diagnostics to detect them.
Read more »
RSV antibody shot for babies hits obstacles in rollout: 'As pediatricians, we're angry'RSV season is ramping up, but some doctors are facing challenges getting ahold of a shot that can help protect young children.
Read more »
Local Rates of Flu, RSV Show Up in a City's WastewaterToilet bowls reveal much about the health of a community, alerting scientists to coming outbreaks of flu and other seasonal viruses, researchers say.
Read more »
Now Is the Time for Older Adults to Get the RSV VaccineLike the common cold, RSV generally causes mild symptoms that clear up in a week or so. But, much like the flu, for those who are older and less healthy, RSV can present significant risks.
Read more »
Wear The Gown: The RSV vaccine, the baby, and momRSV season runs from September to January and affects the respiratory system especially in children.
Read more »
Latinas behind RSV, COVID vaccines aim to boost Hispanic ratesLatinos in the U.S. have consistently low inoculation rates against the flu, polio, HPV or hepatitis.
Read more »